Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pathological processes involving the integrity of blood circulation. Hemostasis depends on the integrity of blood vessels, blood fluidity, and blood coagulation. Majority of the hemostatic disorders are caused by disruption of the normal interaction between the vascular endothelium, the plasma proteins (including blood coagulation factors), and platelets.
Biomarker and diagnostic research for vascular hemostatic disease has been reported in the published literature.
6 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and procedural interventions. Pipeline includes 2 PHASE1, 2 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06271252](https://clinicaltrials.gov/study/NCT06271252) |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 2:26 AM UTC
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
PHASE1 |
OriCell Therapeutics Co., Ltd. |
UNKNOWN |
[NCT06571552](https://clinicaltrials.gov/study/NCT06571552) | Coagulation Disorders Secondary to Two Plasmapheresis Techniques (Double Filtration Plasmapheresis vs. PFS). Descriptive Pilot Study. | NA | Centre Hospitalier Universitaire de Nīmes | RECRUITING |
[NCT07410130](https://clinicaltrials.gov/study/NCT07410130) | Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate | — | Assiut University | NOT_YET_RECRUITING |
[NCT06328647](https://clinicaltrials.gov/study/NCT06328647) | Quantra Point-of-Care Hemostasis Monitoring | NA | The Cleveland Clinic | ACTIVE_NOT_RECRUITING |
[NCT06242353](https://clinicaltrials.gov/study/NCT06242353) | Coagulopathy in Childhood Acute Lymphoblastic Leukaemia | — | Karolinska University Hospital | UNKNOWN |
219 publications have been identified in PubMed for vascular hemostatic disease. Research spans Review / Meta-Analysis (30%), Basic Science / Preclinical (24%), and Clinical Trial Publication (19%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 55 | 30% |
Laboratory research | 44 | 24% |
Clinical study results | 35 | 19% |
Disease patterns and progression | 17 | 9% |
New treatment approaches | 17 | 9% |
Testing and diagnosis research | 8 | 4% |
Patient case studies | 6 | 3% |
Other research | 2 | 1% |
Fiori A (2026). [PMID: 41376157](https://pubmed.ncbi.nlm.nih.gov/41376157/). *Molecular therapy : the journal of the American Society of Gene Therapy*. [Gene Therapy / Novel Therapeutics]
Tu C (2026). [PMID: 41513030](https://pubmed.ncbi.nlm.nih.gov/41513030/). *Cancer Lett*. [Basic Science / Preclinical]
Zabaleta A (2026). [PMID: 41610428](https://pubmed.ncbi.nlm.nih.gov/41610428/). *Blood*. [Diagnostic / Biomarker]
Liu Y (2026). [PMID: 41529091](https://pubmed.ncbi.nlm.nih.gov/41529091/). *Cancer Res*. [Gene Therapy / Novel Therapeutics]
An N (2026). [PMID: 41882404](https://pubmed.ncbi.nlm.nih.gov/41882404/). *Nat Med*. [Clinical Trial Publication]
Blumenberg V (2026). [PMID: 41592291](https://pubmed.ncbi.nlm.nih.gov/41592291/). *Blood*. [Case Report / Case Series]
Li L (2026). [PMID: 41891922](https://pubmed.ncbi.nlm.nih.gov/41891922/). *J Exp Med*. [Basic Science / Preclinical]
Zanwar S (2026). [PMID: 41484090](https://pubmed.ncbi.nlm.nih.gov/41484090/). *Blood Cancer J*. [Epidemiology / Natural History]
Du T (2026). [PMID: 41632828](https://pubmed.ncbi.nlm.nih.gov/41632828/). *Blood*. [Epidemiology / Natural History]
Mohty M (2026). [PMID: 41807348](https://pubmed.ncbi.nlm.nih.gov/41807348/). *Blood Cancer J*. [Review / Meta-Analysis]